CrossRef Text and Data Mining

Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.

Gemcitabine and Docetaxel Combination for Advanced Soft Tissue Sarcoma: A Nationwide Retrospective Study

Yunjung Choi, Mi Sun Yun, Sang Hee Lim, Jeeyun Lee, Jin-Hee Ahn, Yu Jung Kim, Kyong Hwa Park, Young Suk Park, Ho Yeong Lim, Hyonggin An, Dong-Churl Suh, Yeul Hong Kim

Cancer Research and Treatment. 2018;50(1):175-182. Published online 2017 March 30 DOI: https://doi.org/10.4143/crt.2016.535

Gemcitabine and Docetaxel Combination for Advanced Soft Tissue Sarcoma: A Nationwide Retrospective Study

Yunjung Choi, Mi Sun Yun, Sang Hee Lim, Jeeyun Lee, Jin-Hee Ahn, Yu Jung Kim, Kyong Hwa Park, Young Suk Park, Ho Yeong Lim, Hyonggin An, Dong-Churl Suh, Yeul Hong Kim

Cancer Research and Treatment. 2018;50(1):175-182

Link1

Link2 Link3

Outcomes of gemcitabine-docetaxel as second-line chemotherapy in patients of advanced soft tissue sarcoma: A retrospective analysis

K. Gupta, S. Parthiban, S. Kumar, S. Srinivas, D.H. Vallathol, R. Chanana, G.S. Grewal, N. Rathnasamy, A. Goel, J. Bajpai

Annals of Oncology. 2018;29:ix128

Link1 Link2 Link3

Gemcitabine Plus Anlotinib Is Effective and Safe Compared to Gemcitabine Plus Docetaxel in Advanced Soft Tissue Sarcoma

Zhiyong Liu, Xin Wang, Jiaqiang Wang, Peng Zhang, Chao Li, Bangmin Wang, Guancong Liu, Weitao Yao

Frontiers in Oncology. 2022;12:

Link1

Soft tissue sarcoma in adolescent and young adult patients: A retrospective study using a nationwide bone and soft tissue tumor registry in Japan.

Takashi Fukushima, Koichi Ogura, Toru Akiyama, Katsushi Takeshita, Akira Kawai

. 2020;

Link1 Link2

Phase IB study of the combination of docetaxel, gemcitabine, and bevacizumab in patients with advanced or recurrent soft tissue sarcoma: the Axtell regimen

C.F. Verschraegen, H. Arias-Pulido, S.-J. Lee, S. Movva, L.A. Cerilli, S. Eberhardt, B. Schmit, R. Quinn, C.Y. Muller, I. Rabinowitz, M. Purdy, D. Snyder, T. Bocklage

Annals of Oncology. 2012;23(3):785-790

Link1 Link2 Link3

Fourteen-Day Gemcitabine-Docetaxel Chemotherapy Is Effective and Safer Compared to 21-Day Regimen in Patients with Advanced Soft Tissue and Bone Sarcoma

Minggui Pan, Maily K. Trieu, Manpreet Sidhu, Jeanette Yu, Tiffany Seto, Kristen Ganjoo

Cancers. 2021;13(8):1983

Link1

Phase II study of weekly docetaxel and fixed dose rate gemcitabine in patients with previously treated advanced soft tissue and bone sarcoma

Eun Mi Lee, Sun Young Rha, Jeeyun Lee, Kyong Hwa Park, Jin-Hee Ahn

Cancer Chemotherapy and Pharmacology. 2011;69(3):635-642

Link1

Link2 Link3

Soft tissue sarcoma in adolescent and young adult patients: a retrospective study using a nationwide bone and soft tissue tumor registry in Japan

Takashi Fukushima, Koichi Ogura, Toru Akiyama, Katsushi Takeshita, Akira Kawai

Japanese Journal of Clinical Oncology. 2021;51(7):1080-1087

Link1

Link2

Albumin-bound paclitaxel and gemcitabine combination therapy in soft tissue sarcoma

Zhichao Tian, Fan Zhang, Po Li, Jiaqiang Wang, Jinpo Yang, Peng Zhang, Weitao Yao, Xin Wang

. 2020;

Link1 Link2

Albumin-bound paclitaxel and gemcitabine combination therapy in soft tissue sarcoma

Zhichao Tian, Fan Zhang, Po Li, Jiaqiang Wang, Jinpo Yang, Peng Zhang, Weitao Yao, Xin Wang

. 2020;

Link1 Link2

This metadata service is kindly provided by CrossRef from May 29, 2014. Cancer Res Treat has participated in CrossRef Text and Data Mining service since October 29, 2014.